Click Here for 5% Off Your First Aladdin Purchase!

galidesivir , Replicase polyprotein 1ab inhibitor, CAS No.249503-25-1, Replicase polyprotein 1ab inhibitor

  • Moligand™
Item Number
G610487
Grouped product items
SKUSizeAvailabilityPrice Qty
G610487-5mg
5mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$310.90
G610487-25mg
25mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$1,060.90

Basic Description

SynonymsGalidesivir|249503-25-1|IMMUCILLIN A|Immucillin-A|BCX4430|BCX-4430|BCX 4430 Free Base|(2S,3S,4R,5R)-2-(4-amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)-5-(hydroxymethyl)pyrrolidine-3,4-diol|OLF97F86A7|BCX4430 freebase|ImmA cpd|3,4-Pyrrolidinediol,2-(4-Amino-5h-Py
GradeMoligand™
Action TypeINHIBITOR
Mechanism of actionReplicase polyprotein 1ab inhibitor

Product Properties

ALogP-2.1

Associated Targets

PNP Tclin Purine nucleoside phosphorylase 1 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

Names and Identifiers

IUPAC Name (2S,3S,4R,5R)-2-(4-amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)-5-(hydroxymethyl)pyrrolidine-3,4-diol
INCHI InChI=1S/C11H15N5O3/c12-11-8-6(14-3-15-11)4(1-13-8)7-10(19)9(18)5(2-17)16-7/h1,3,5,7,9-10,13,16-19H,2H2,(H2,12,14,15)/t5-,7+,9-,10+/m1/s1
InChi Key AMFDITJFBUXZQN-KUBHLMPHSA-N
Canonical SMILES C1=C(C2=C(N1)C(=NC=N2)N)C3C(C(C(N3)CO)O)O
Isomeric SMILES C1=C(C2=C(N1)C(=NC=N2)N)[C@H]3[C@@H]([C@@H]([C@H](N3)CO)O)O
Alternate CAS 249503-25-1
PubChem CID 10445549
MeSH Entry Terms 2-(4-amino-5H-pyrrolo(3,2-d)pyrimidin-7-yl)-5-(hydroxymethyl)pyrrolidine-3,4-diol;BCX-4430;BCX4430;Galidesivir;ImmA cpd;immucillin A;immucillin-A
Molecular Weight 265.27

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Related Documents

References

1. Warren TK, Wells J, Panchal RG, Stuthman KS, Garza NL, Van Tongeren SA, Dong L, Retterer CJ, Eaton BP, Pegoraro G et al..  (2014)  Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430..  Nature,  508  (7496): (402-5).  [PMID:24590073]
2. Bernatchez JA, Tran LT, Li J, Luan Y, Siqueira-Neto JL, Li R.  (2020)  Drugs for the Treatment of Zika Virus Infection..  J Med Chem,  63  (2): (470-489).  [PMID:31549836]
3. Choy KT, Wong AY, Kaewpreedee P, Sia SF, Chen D, Hui KPY, Chu DKW, Chan MCW, Cheung PP, Huang X et al..  (2020)  Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro..  Antiviral Res,  178  (3): (104786).  [PMID:32251767]

Solution Calculators